APA (7th ed.) Citation

Licitra, L., Mesia, R., Rivera, F., Remenár, É., Hitt, R., Erfán, J., . . . Vermorken, J. B. (2011). Evaluation of EGFR gene copy number as a predictive biomarker for the efficacy of cetuximab in combination with chemotherapy in the first-line treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck: EXTREME study. Annals of Oncology, 22(5), 1078. https://doi.org/10.1093/annonc/mdq588

Chicago Style (17th ed.) Citation

Licitra, L., et al. "Evaluation of EGFR Gene Copy Number as a Predictive Biomarker for the Efficacy of Cetuximab in Combination with Chemotherapy in the First-line Treatment of Recurrent And/or Metastatic Squamous Cell Carcinoma of the Head and Neck: EXTREME Study." Annals of Oncology 22, no. 5 (2011): 1078. https://doi.org/10.1093/annonc/mdq588.

MLA (9th ed.) Citation

Licitra, L., et al. "Evaluation of EGFR Gene Copy Number as a Predictive Biomarker for the Efficacy of Cetuximab in Combination with Chemotherapy in the First-line Treatment of Recurrent And/or Metastatic Squamous Cell Carcinoma of the Head and Neck: EXTREME Study." Annals of Oncology, vol. 22, no. 5, 2011, p. 1078, https://doi.org/10.1093/annonc/mdq588.